KELLY DAHMS: Open Payments
NPI 1790294684 · SCHAUMBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,950 in 90 payments from 17 companies in 2025. Trend: 2023 $994 · 2024 $556 · 2025 $1,950
Food & beverage: $1,850Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $419 |
| Janssen Biotech, Inc. | 11 | $304 |
| Novartis Pharmaceuticals Corporation | 6 | $215 |
| Incyte Corporation | 9 | $204 |
| Galderma Laboratories, L.P. | 17 | $187 |
| GENZYME CORPORATION | 3 | $111 |
| Organon LLC | 6 | $106 |
| UCB, Inc. | 3 | $100 |
| Amgen Inc. | 4 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
Products named: TREMFYA, RINVOQ, OPZELURA, SKYRIZI, DUPIXENT, AKLIEF, Bimzelx, OTEZLA.
Industry payments across IL — which companies pay providers there.
